BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang M, Zhang CY. Diagnostic biomarkers for pancreatic cancer: An update. World J Gastroenterol 2021; 27(45): 7862-7865 [PMID: 34963749 DOI: 10.3748/wjg.v27.i45.7862]
URL: https://www.wjgnet.com/2218-4333/full/v27/i45/7862.htm
Number Citing Articles
1
Melissa M. Elder, Yves Paul Vincent Mbous, Toni Marie Rudisill, George A. Kelley. Screening for pancreatic cancer among smokers as high-risk individuals: Systematic review and meta-analysis of prospective cohort studiesHealth Sciences Review 2024; 13: 100203 doi: 10.1016/j.hsr.2024.100203
2
Safia Samir, Mohamed El-Ashry, Waleed Soliman, Marwa Hassan. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approachComputational Biology and Chemistry 2024; 112: 108171 doi: 10.1016/j.compbiolchem.2024.108171
3
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment optionsWorld Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
4
Sophia G. Kisling, Pranita Atri, Ashu Shah, Jesse L. Cox, Sunandini Sharma, Lynette M. Smith, Dario Ghersi, Surinder K. Batra. A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal AdenocarcinomaClinical Cancer Research 2023; 29(18): 3759 doi: 10.1158/1078-0432.CCR-23-0825
5
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, Jade Gambill, Diksha Mahendru, Chandler H. Park, Yan Leyfman. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. PishvaianCancers 2024; 16(13): 2329 doi: 10.3390/cancers16132329
6
Zahra Yousefli, Nilofar Rafiee, Tanin Nourollahian, Amirreza Alipour, Zahra Haghshenas, Muhammad Islampanah, Majid Khazaei, Hamid Fiuji, Seyed Mahdi Hassanian, Gordon A Ferns, Elham Nazari, Amir Avan. Recent Advances of Circulating Biomarkers with Potential Diagnostic, Prognostic, and Therapeutic Value in Pancreatic Cancer; Limitations of Clinical Application.Pathology - Research and Practice 2025; : 156045 doi: 10.1016/j.prp.2025.156045
7
Yu Chen, Jialun Wang, Qiyuan Guo, Xihan Li, Xiaoping Zou. Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic CancerCancers 2022; 14(21): 5439 doi: 10.3390/cancers14215439
8
Fatemeh Tajik, Fahimeh Fattahi, Fereshteh Rezagholizadeh, Behnaz Bouzari, Pegah Babaheidarian, Masoud Baghai Wadji, Zahra Madjd. Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumorsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46484-3
9
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancerArchives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03914-8
10
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progressionWorld Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
11
Amir Sherchan, Feng Jin, Bhakti Sherchan, Sujit Kumar Mandal, Binit Upadhaya Regmi, Ranita Ghising, Sandesh Raj Upadhaya, Bishnu Gautam, Dipendra Pathak, Maoquan Li. Clinical significance of risk factor analysis in pancreatic cancer by using supervised model of machine learningFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1551926
12
Qian Zhao, Yan Wang, Tianyu Huo, Furong Li, Lu Zhou, Yongliang Feng, Zhigang Wei. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating ScaleJournal of Clinical Medicine 2023; 12(1): 358 doi: 10.3390/jcm12010358
13
Luoluo Wang, Shuping Zhou, Yi Ruan, Xiang Wu, Xueming Zhang, Yi Li, Dongjian Ying, Yeting Lu, Yuan Tian, Gong Cheng, Jing Zhang, Kaiji Lv, Xinhua Zhou. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5pMolecular Biotechnology 2025; 67(2): 762 doi: 10.1007/s12033-024-01091-z